Strs Ohio Takes Position in Chemed Corporation $CHE

Key Points

• Strs Ohio acquired a stake of 2,732 shares in Chemed Corporation, valued at approximately $1.68 million, during the first quarter.
• The company's quarterly earnings report showed an EPS of $4.27, missing analysts' expectations, with revenue of $618.8 million, but up 3.8% year-over-year.
• Chemed recently increased its quarterly dividend to $0.60 per share, representing a $2.40 annualized dividend and a yield of 0.5%, up from the previous $0.50 per share.

Strs Ohio bought a new stake in shares of Chemed Corporation (NYSE:CHE - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 2,732 shares of the company's stock, valued at approximately $1,681,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Chemed by 16.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,358 shares of the company's stock worth $1,779,000 after acquiring an additional 482 shares during the period. Nuveen Asset Management LLC lifted its holdings in Chemed by 18.0% during the 4th quarter. Nuveen Asset Management LLC now owns 39,451 shares of the company's stock valued at $20,901,000 after purchasing an additional 6,005 shares during the last quarter. Quantinno Capital Management LP grew its position in shares of Chemed by 5.4% during the 4th quarter. Quantinno Capital Management LP now owns 1,673 shares of the company's stock worth $886,000 after buying an additional 86 shares during the period. Snowden Capital Advisors LLC boosted its holdings in shares of Chemed by 17.4% in the fourth quarter. Snowden Capital Advisors LLC now owns 1,105 shares of the company's stock valued at $585,000 after buying an additional 164 shares during the period. Finally, Twinbeech Capital LP bought a new position in shares of Chemed in the fourth quarter valued at about $2,506,000. Institutional investors own 95.85% of the company's stock.

Chemed Price Performance

NYSE CHE traded down $6.10 during trading hours on Friday, hitting $452.15. The company had a trading volume of 320,827 shares, compared to its average volume of 185,768. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The firm's 50 day moving average is $450.46 and its 200 day moving average is $526.54. The company has a market capitalization of $6.59 billion, a price-to-earnings ratio of 23.25, a P/E/G ratio of 2.67 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The company had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. During the same quarter in the prior year, the business earned $5.47 EPS. Chemed's revenue was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, equities analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were given a $0.60 dividend. This is a boost from Chemed's previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's payout ratio is 12.34%.

Insiders Place Their Bets

In other Chemed news, Director Patrick P. Grace sold 150 shares of the firm's stock in a transaction dated Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the transaction, the director directly owned 3,397 shares of the company's stock, valued at $1,574,135.83. This trade represents a 4.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the business's stock in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $421.91, for a total transaction of $4,224,162.92. The disclosure for this sale can be found here. Corporate insiders own 3.29% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CHE. Wall Street Zen downgraded shares of Chemed from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Oppenheimer dropped their price objective on Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Bank of America decreased their price objective on Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a report on Wednesday, September 10th. Royal Bank Of Canada dropped their price objective on Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Finally, Jefferies Financial Group raised Chemed from a "hold" rating to a "buy" rating and raised their price objective for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $578.50.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.